<DOC>
	<DOCNO>NCT02732808</DOCNO>
	<brief_summary>This study prospective &amp; clinical trial investigate efficacy double stimulation follicular luteal phase patient poor ovarian response undergo IVF intracytoplasmic sperm injection ( ICSI ) cycle . The study protocol approve Ethics Committee ( Institutional Review Board ) Royan institute . The study conduct accord Declaration Helsinki medical research . All participant provide inform consent counsel infertility treatment routine IVF/ICSI program . All patient diagnose poor ovarian responder ( POR ) base Bologna criterion eligible participation study . In order define poor response IVF , least two follow three feature must present : ( ) advance maternal age risk factor POR ; ( ii ) previous POR ; ( iii ) abnormal ovarian reserve test ( ORT ) . Two episode POR maximal stimulation sufficient define patient poor responder absence advance maternal age abnormal ORT . Stage one treatment protocol First stimulation performs Clomiphene citrate ( Ovumid® , Iran Hormones Company ) 25 mg/day co-treatment Letrozole ( Letrofem® , Iran Hormones Company ) 2.5 mg/day give cycle day 3 onwards . Letrozole give 4 day clomiphene citrate continuously use trigger day . Patients start inject human menopausal gonadotrophin ( HMG ) ( Menopur® , Ferring , Switzerland ) 150 IU every day begin cycle day 6 . When one two dominant follicle ( 18 mm diameter ) observe , final stage oocyte maturation induce triptorelin 100 μg ( Decapeptyl® ; Ferring GmbH , Germany ) follow ibuprofen 600 mg ( Ibuprofen-Najo® , Coated Tablets , Najo Company , Iran ) use day oocyte maturation trigger day . After first oocyte retrieval , human menopausal gonadotrophin letrozole administrate stimulate follicle development , oocyte retrieval carry second time dominant follicle mature . All highest-quality embryo ( include grade 1 grade 2 , eight-cell blastomere embryos ) cryopreserved vitrification method third day oocyte retrieval . Stage two treatment protocol : Transvaginal ultrasound evaluation performs oocyte retrieval determine whether continue second ovarian stimulation . The criterion continue stimulation presence least two antral follicle 2-8 mm diameter . A total 225 IU HMG ( Menopur® , Ferring , Switzerland ) letrozole 2.5 mg ( Letrofem® , Iran Hormones Company ) administer daily day , day , oocyte retrieval . The initial second stage follicular monitoring conduct 5-7 day later , follow every 2-4 day , use transvaginal ultrasound evaluation , record number develop follicle . Letrozole administration discontinue dominant follicle reach diameter 12 mm , give large follicle redundant LH FSH receptor , good response exogenous hormone stimulation . Daily administration medroxyprogesterone acetate 10 mg ( Progestrone® , 5mg bid ; Aboureihan , Iran ) add begin stimulation day 12 case post-ovulation follicle size small 14 mm diameter stimulation need continue several day . This perform postpone menstruation avoid oocyte retrieval menstruation , prevent risk infection procedure . When three dominant follicle reach diameter 18 mm one mature dominant follicle exceed 20 mm , final stage oocyte maturation induce triptorelin 100 μg ( Decapeptyl® ; Ferring GmbH , Germany ) injection . Again , ibuprofen 600 mg ( Ibuprofen-Najo® , Coated Tablets , Najo Company , Iran ) use day oocyte maturation trigger day . Transvaginal ultrasound-guided oocyte retrieval conduct 32-36 h GnRH agonist administration . All retrieve oocyte treat study stage one .</brief_summary>
	<brief_title>Dual Ovarian Stimulation Same IVF/ICSI Cycles Treatment Poor Ovarian Responders</brief_title>
	<detailed_description>Data collection perform use questionnaire fill per available record laboratory result . The mean total number retrieve oocytes embryos present protocol compare mean total number retrieve oocyte embryos previous routine cycle .</detailed_description>
	<mesh_term>Infertility</mesh_term>
	<criteria>Diagnosis Poor ovarian response ( POR ) , accord Bologna criterion : patient least two follow criterion : age 40 year ; history ovarian surgery ; previous treatment use conventional protocol yield less three oocyte ; antral follicle count le 5 menstrual cycle day 23 ; basal serum Follicle Stimulating Hormone ( FSH ) concentration 10 19 IU/l . ovarian failure include basal Follicle Stimulating Hormone ( FSH ) 20 IU/l antral follicle ultrasound examination ; Endometriosis grade 3 high ; Any contraindication ovarian stimulation treatment .</criteria>
	<gender>Female</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>February 2016</verification_date>
	<keyword>Double stimulation</keyword>
	<keyword>luteal-phase ovarian stimulation</keyword>
	<keyword>poor ovarian response</keyword>
</DOC>